Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia
PeerJ · 2023
DOI: 10.7717/peerj.14849 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Louise Woodhams und 3 weiteren Autor:innen. Beteiligte Einrichtung: Curtin Medical School, Curtin University, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Community Pharmacy Services. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Community pharmacists have regular interactions with people living with type 2 diabetes to supply medications, and have a potential role in supporting other primary care professionals in the screening, management, monitoring and facilitation of timely referral of microvascular complications. This study aimed to investigate the contemporary and future roles of community pharmacists in diabetes-related microvascular complication management.
Methods
This study involved an online Australian nation-wide survey of pharmacists administered via Qualtrics® and distributed through social media platforms, state and national pharmacy organisations, and via major banner groups. Descriptive analyses were undertaken using SPSS.
Results
Among 77 valid responses, 72% of pharmacists already provided blood pressure and blood glucose monitoring services for the management of type 2 diabetes. Only 14% reported providing specific microvascular complication services. Over 80% identified a need for a comprehensive microvascular complication monitoring and referral service, and agreed it is feasible and within the scope of practice of a pharmacist. Almost all respondents agreed that they would implement and provide a monitoring and referral service if provided with appropriate training and resources. Potential barriers to service implementation were competing demands and lack of remuneration and awareness among consumers and health professionals.
Conclusions
Type 2 diabetes services in Australian community pharmacies do not currently focus on microvascular complication management. There appears to be strong support for implementing a novel screening, monitoring and referral service via community pharmacy to facilitate timely access to care. Successful implementation would require additional pharmacist training, and identification of efficient pathways for service integration and remuneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Curtin Medical School, Curtin University, Perth, Western Australia, Australia.
- Medical School, The University of Western Australia, Perth, Western Australia, Australia.
- Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia.
ORCID-Profile: Leanne Chalmers, Graham S Hillis, Tin Fei Sim
Zitieren
APA
Woodhams, L., Chalmers, L., Hillis, G. S., & Sim, T. F. (2023). Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia. PeerJ. https://doi.org/10.7717/peerj.14849
Vancouver
Woodhams L, Chalmers L, Hillis GS, Sim TF. Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia. PeerJ. 2023. doi:10.7717/peerj.14849
BibTeX
@article{Woodhams2023,
author = {Woodhams, Louise and Chalmers, Leanne and Hillis, Graham S and Sim, Tin Fei},
title = {Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia},
journal = {PeerJ},
year = {2023},
doi = {10.7717/peerj.14849}
}
EUVIMED